Mosaic ImmunoEngineering, Inc.
CPMV
$0.98
$0.27839.60%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 787.50K | 867.60K | 883.90K | 964.30K | 1.03M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 1.01M | 1.13M | 1.21M | 1.40M | 1.62M |
Operating Income | -1.01M | -1.13M | -1.21M | -1.40M | -1.62M |
Income Before Tax | -1.06M | -1.21M | -897.70K | -1.01M | -1.24M |
Income Tax Expenses | 0.00 | 0.00 | 0.00 | 2.40K | 2.40K |
Earnings from Continuing Operations | -1.06 | -1.21 | -0.90 | -1.01 | -1.25 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -1.06M | -1.21M | -897.70K | -1.01M | -1.25M |
EBIT | -1.01M | -1.13M | -1.21M | -1.40M | -1.62M |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | -0.15 | -0.17 | -0.12 | -0.14 | -0.17 |
Normalized Basic EPS | -0.09 | -0.10 | -0.11 | -0.12 | -0.14 |
EPS Diluted | -0.15 | -0.17 | -0.13 | -0.14 | -0.18 |
Normalized Diluted EPS | -0.09 | -0.10 | -0.10 | -0.12 | -0.14 |
Average Basic Shares Outstanding | 28.95M | 28.95M | 28.95M | 28.95M | 28.95M |
Average Diluted Shares Outstanding | 28.95M | 28.95M | 30.28M | 30.28M | 30.28M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |